Literature DB >> 6862361

Lower calcitonin levels in young hypogonadic men with osteoporosis.

C Foresta, B Busnardo, G Ruzza, G Zanatta, R Mioni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6862361     DOI: 10.1055/s-2007-1018673

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  8 in total

Review 1.  Androgens and bone.

Authors:  D Vanderschueren; R Bouillon
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

2.  Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement.

Authors:  F H Wong; K K Pun; C Wang
Journal:  Osteoporos Int       Date:  1993-01       Impact factor: 4.507

3.  Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate.

Authors:  M P Collinson; C J Tyrrel; C Hutton
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

4.  Racial differences in calcitonin and katacalcin.

Authors:  J C Stevenson; C H Myers; A B Ajdukiewicz
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

Review 5.  [Calcitonin and osteoporosis--a critical review of the literature 1980-1989].

Authors:  H G Haas; B M Liebrich; W Schaffner
Journal:  Klin Wochenschr       Date:  1990-04-02

6.  Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate.

Authors:  E O Grecu; A Weinshelbaum; R Simmons
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

7.  Testosterone and calcitonin plasma levels in hypogonadal osteoporotic young men.

Authors:  C Foresta; G P Zanatta; B Busnardo; G Scanelli; C Scandellari
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

8.  Successful treatment of low turnover osteoporosis resulting from prolonged reserpine therapy with intermittent calcitonin and phosphate therapy.

Authors:  R C Armamento-Villareal; L V Avioli
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.